Ishara Investments LP 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Ishara Investments LP disclosed 36 US equity positions worth $99.0m in its Q1 2026 13F filing. The largest position was PRAX at 7.3% of the reported book, followed by AXSM and XERS.
What did Ishara Investments LP own in Q1 2026? Top 36 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 7.3% | $7.3m | 22,550 | – | |
| 2 | AXSM AXSOME THERAPEUTICS INC. | Healthcare | 7.0% | $6.9m | 41,000 | – | |
| 3 | XERS XERIS BIOPHARMA HOLDINGS INC | Healthcare | 6.0% | $5.9m | 1,025,000 | – | |
| 4 | 4XC1 KALVISTA PHARMACEUTICALS INC | 5.6% | $5.6m | 276,750 | – | ||
| 5 | AM6 AMICUS THERAPEUTIC | 5.4% | $5.3m | 369,000 | – | ||
| 6 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 4.7% | $4.6m | 82,000 | – | |
| 7 | VSTM VERASTEM INC | Healthcare | 4.4% | $4.3m | 820,000 | – | |
| 8 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 3.7% | $3.7m | 174,250 | – | |
| 9 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 3.5% | $3.5m | 55,350 | – | |
| 10 | PCVX VAXCYTE INC | Healthcare | 3.4% | $3.3m | 57,400 | – | |
| 11 | VERA VERA THERAPEUTICS INC | Healthcare | 3.3% | $3.3m | 82,000 | – | |
| 12 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 3.3% | $3.3m | 110,700 | – | |
| 13 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 3.3% | $3.2m | 174,250 | – | |
| 14 | ZNTL ZENTALIS PHARMACEUTICALS INC | Healthcare | 2.9% | $2.9m | 1,230,000 | – | |
| 15 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 2.8% | $2.8m | 57,400 | – | |
| 16 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 2.8% | $2.7m | 123,000 | – | |
| 17 | ARDX ARDELYX INC | Healthcare | 2.7% | $2.7m | 451,000 | – | |
| 18 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 2.2% | $2.2m | 82,000 | – | |
| 19 | GMAB GENMAB A/S | Healthcare | 2.2% | $2.2m | 82,000 | – | |
| 20 | DBVT DBV TECHNOLOGIES S A | 2.2% | $2.1m | 102,500 | – | ||
| 21 | CATALYST PHARMACEUTICALS INC | 2.1% | $2.0m | 82,000 | – | ||
| 22 | SION SIONNA THERAPEUTICS INC | Healthcare | 2.0% | $2.0m | 49,200 | – | |
| 23 | CTNM CONTINEUM THERAPEUTICS INC | 1.9% | $1.9m | 142,000 | – | ||
| 24 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 1.7% | $1.7m | 5,125 | – | |
| 25 | LGND LIGAND PHARMACEUTICALS INC | Healthcare | 1.7% | $1.6m | 8,200 | – | |
| 26 | EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 1.6% | $1.5m | 49,200 | – | |
| 27 | IMTX IMMATICS N.V | Healthcare | 1.5% | $1.5m | 153,750 | – | |
| 28 | LXRX LEXICON PHARMACEUTICALS INC | Healthcare | 1.4% | $1.4m | 902,000 | – | |
| 29 | BEAM BEAM THERAPEUTICS INC | Healthcare | 1.4% | $1.4m | 57,400 | – | |
| 30 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 1.3% | $1.3m | 102,500 | – | |
| 31 | NEWAMSTERDAM PHARMA COMPANY | 1.2% | $1.2m | 36,900 | – | ||
| 32 | ANNX ANNEXON INC | Healthcare | 1.0% | $965.3k | 174,250 | – | |
| 33 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 0.8% | $819.7k | 24,600 | – | |
| 34 | SLN SILENCE THERAPEUTICS PLC | 0.7% | $740.4k | 140,500 | – | ||
| 35 | PTCT PTC THERAPEUTICS INC | Healthcare | 0.7% | $698.3k | 10,250 | – | |
| 36 | GOSS GOSSAMER BIO INC | Healthcare | 0.3% | $269.4k | 820,000 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.